Bio-Rad HIV test recall
This article was originally published in The Gray Sheet
Executive Summary
Single lot of microwell plates performing outside expected ranges for the Genetic Systems HIV-1/HIV-2 peptide EIA qualified enzyme immunoassays test kits spawns recall, CBER announces Oct. 3. Detecting antibodies in human serum and plasma, the tests screen blood and blood products intended for transfusion or further manufacture into plasma products. Consignees are asked to contact the manufacturer to arrange for product return...
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.